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Abstract
Introduction: Catalase decomposes hydrogen peroxide into oxygen and water. Its low 
concentration could be involved in signaling while its high concentration is toxic.
Aim: This short review discusses the association of blood catalase and diabetes mellitus in 
Hungarian diabetic patients.
Results: Several cohort studies showed decreased blood catalase activity in type 2 diabetes 
and in gestational diabetes. 
Among the catalase gene polymorphisms rs769217 showed a weak association with type 1 
diabetes. Regarding rs1001179 polymorphism patients with TT genotype have a risk for lower life 
expectancy. 
In acatalasemics the frequency of diabetes mellitus is higher (P˂0.001) than in the Hungarian 
population. 11 of 12 known Hungarian acatalasemia mutations are found in diabetic patients. 
Acatalasemia may be associated with a higher risk for diabetes mellitus especially for its type 2 form.
Acatalasemia mutations could explain the decreased (˂50%) blood catalase activities only in 
17.4% of the cases. 
Conclusions: Blood catalase activity is decreased in type 2 and gestional diabetes. Patients 
with inherited catalase deficiency and known acatalasemia mutation are at higher risk of diabetes 
mellitus.
The lifelong effect of oxidative damage on the oxidant sensitive, insulin producing pancreatic 
beta-cells could contribute to the manifestation of diabetes mellitus especially to type 2 form.
Acatalasemia mutations could explain the reason for the catalase decrease while for the other 
(82.6 %) cases it remains unsolved.
The decreased blood catalase activity in type 2 and gestational diabetes rather due to regulatory 
mechanisms than to the catalase gene mutations.
NM_001752.3, NP1743.1) has 13 exons, 12 introns and 33,135 
nucleotides [4].
Diabetes mellitus is a metabolic disorder characterized by 
hyperglycemia and either insufficiency of insulin secretion or 
diminished insulin sensitivity. Gestational diabetes occurs with 
variable severity in 3%-5% of all pregnancies. It is related to oxidative 
stress and impaired antioxidant defense [5]. Furthermore, Hur et 
al., conducted a web-based search for genes associated with reactive 
oxygen species and diabetes mellitus. This search showed that among 
the targets insulin was the first and catalase the second [6]. 
There are several reports on decreased blood catalase activities 
in diseases of Hungarian subjects [7-10]. The main reasons for the 
blood catalase decrease might be caused by gene polymorphisms and 
mutations as well as regulatory mechanisms [11,12].
Introduction
Human enzyme catalase (EC 1.11.1.6, BCBI: 9060) decomposes 
hydrogen peroxide into oxygen and water. Low concentration of 
hydrogen peroxide plays an important role in signaling while its 
high concentration is toxic [1]. Decreased activity of catalase may 
lead to an increase of hydrogen peroxide concentration which 
may contribute to the manifestation of various age related diseases 
including diabetes mellitus [2]. Human tissues such as erythrocytes 
and liver have the highest concentrations of catalase, and more than 
99 % of blood catalase derives from the erythrocytes. Therefore, blood 
catalase activity is expressed in M (mega: 106) units per liter of blood 
(MU/L). Reference range of blood catalase activity is 113±16.5 MU/L 
[3].
The human catalase gene (CAT, NCBI Gene ID: 847, 
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In this mini review, we discuss the blood catalase activity in 
different types of diabetes mellitus. For explanation of decreased 
blood catalase activity in type 2 and gestational diabetes the effects 
of catalase gene polymorphisms on catalase activity was examined. 
Furthermore, the mutational search of the catalase gene exons in 
diabetics with highly decreased blood catalase activity is explained. 
Finally, the association of acatalasemia and type 2 diabetes is 
evaluated. 
Discussion and Results
Blood catalase activities in diabetes mellitus
For Hungarain patients with type 1, type 2 and gestational 
diabetes four papers report on the results of the determination of 
blood catalase activities [7-9,13].
In a total of 137 randomly selected diabetic patients (type 1:45, 
type 2: 92) the mean blood catalase activity was 94.4±19.2 MU/L. 
It means a significant (P 0.001) decrease when compared to that of 
reference range (113.3±16.5 MU/L) [7].
The mean activity of blood catalase was decreased (P0.001) 
in pregnant patients without diabetes (89±18 MU/L, n: 169) when 
compared to the control group of females (109±13 MU/L, n: 235). 
For diabetic pregnants the blood catalase (74±14 MU/L, n: 60) was 
decreased (P0.001) when compared either to that of controls (89±18 
MU/L) or to those of pregnant without diabetes (89±18 MU/L [8].
For another cohort (diabetes type 1: 106, type 2: 100, gestational: 
33, control: 60) the blood catalase activity was decreased in two 
types (type 2: 71.2±14.6 MU/L, P0.001, gestational: 68.5±12.2 MU/L, 
P0.001) of diabetes mellitus, while it was unchanged (P0.05) in type 1 
(102.5 MU/L) when compared to that of controls (104.7±18.5 MU/L). 
In the group of type 2 diabetic the blood catalase decreased with age 
(P: 0.043) showing the highest activities (78.9±10.8 MU/L) between 
20 and 40 years of age and the lowest ones (68.0±14.4 MU/L) for elder 
patients between 61 and 80 years [9]. 
A further cohort with a more diabetic patients (type 1: 115, type 
2: 225) and controls (n: 295) yielded similar results. Blood catalase of 
type 1 diabetics was not changed (101±24 MU/L, P0.05) while type 
2 diabetics had significantly (P0.001) lower blood catalase compared 
either to type1 diabetics or to controls (104±15 MU/L) [13].
These studies clearly showed that blood catalase activity decreases 
in type 2 and gestational diabetes while it does not change in type 
1 diabetes mellitus. For genetic explanation of this decrease the 
examination of catalase gene polymorphisms and mutations might 
give an answer. 
rs769217 and rs11001179 catalase gene 
polymorphisms in Hungarian diabetic patients 
To date 748 single nucleotide polymorphisms (SNPs) have 
been reported for the human catalase gene [14], including 89 SNPs 
(59 missense, 29 synonymous, and 1 nonsense) in the exons [15]. 
Among the several SNPs only two attracted studies in details on 
diabetes mellitus. These two polymorphisms are the C111T in exon 
9 (+22348C→T, rs769217, Asp389Asp) and -262C→T (rs1001179) 
which is located 262 base pairs from the transcription start site.
rs769217 polymorphism 
This polymorphism was described by Wen in 1990 [14]. The 
effect of this polymorphism on blood catalase activity in patients with 
diabetes mellitus was examined firstly in Hungarian patients [9,13]. 
For type 2 diabetes the blood catalase activity was decreased 
(P0.005) in every genotypes (TT: 91±24 MU/L, CT: 90±24 MU/L, TT: 
95±15 MU/L) when compared either to those of controls or to type 1 
diabetics without differences in genotypes (P0.05). 
For type 1 diabetics the TT genotype frequencies were higher 
(P0.02) than in type 2 diabetics and controls. Furthermore, the 
C allele frequency was higher than that of T allele in both types 
of diabetes (type 1 C: 0.68, T: 0.32, type 2 C: 0.72, T: 0.28) and in 
controls (C: 0.72, T: 0.28). From these data may be concluded that 
the rs769217 polymorphism yielded a weak association with type 
1 diabetes mellitus (OR: 1.25, 0.9CI: 0.90-1.75). Furthermore, this 
silent polymorphism yielded no association with type 2 diabetes 
mellitus. For several cases the recent evidence has indicated that silent 
(synonymous) mutations may affect splicing and/or mRNA stability 
causing slower transcription from the mutant allele than from the 
wild allele [17].
rs11001179 polymorphism 
Forsberg et al. reported on the -262C→T polymorphism in the 
5’-region of the catalase gene that might have impact on catalase 
protein expression. In 29 Swedish controls they found that the 
subjects with T alleles had higher (P0.03) catalase activities [18]. For 
explanation, they assumed that the variant promoter sequence region 
can bind different transcription factors, which could explain the 
differences in promoter activity.
Chistiakov et al., reported on susceptibility of this polymorphism 
to type 1 diabetes mellitus in Russian population [19], but this 
susceptibility was not affirmed in UK and US populations [20].
In Hungarian diabetics and controls [13], the examination of 
this polymorphism showed decreased blood catalase activity for CC 
(98±30 MU/L), CT (88±34 MU/L) and TT (84±23) genotypes of type 
2 diabetics compared to those (CC:109±25 MU/L, CT: 102±16 MU/L, 
TT: 103±17 MU/L) of the controls. The three genotypes had similar 
(P0.6) blood catalase activities and it did not yielded difference (P0.2) 
between types 1 and type 2 diabetics. These results showed that this 
polymorphisms could not explain the decrease in blood catalase 
activity, as all genotypes yielded the same change.
Further analyses of this polymorphisms revealed interesting 
findings. For type 2 diabetics it was detected that the mean age of 
patients with CC genotype (62±10 years) was higher (P0.006) than 
those of with TT genotype (54±9 years) without change in age of 
disease onset or disease duration. Furthermore, in the sulphonylurea 
treated group the number of type 2 diabetics was lower (P0.001) in 
TT genotype when compared to those with CC genotype (OR: 6.18, 
0.95CI:2.39-15.9) or to all type 2 diabetics (OR: 3.36 0.95CI: 1.61-
7.03). For explanation, we could assume that the sulphonylurea 
treatment of diabetics with TT genotype may have been less effective 
and the clinicians may have opted for other treatment. Furthermore, 
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this group of diabetics had decreased HDL and increased levels of 
glucose, hemoglobin A1c, cholesterol and ApoB. These results may 
suggest that diabetics with TT genotype of rs11001179 polymorphism 
have a risk for lower life expectancy due to their decreased blood 
catalase and their pathological carbohydrate and lipid biomarkers.
Contrary to findings in Swedish controls [18], these results showed 
the lowest blood catalase activities to the TT genotype similarly (P06) 
to the other two genotypes. Furthermore, the higher risks of these 
patients with the TT genotype suggests that this polymorphism might 
have an effect on other regulatory mechanisms of diabetes mellitus. 
Mutational screening of catalase gene exons in 
diabetic patients with less than half of blood catalase 
activity [21,22]
Examination of possible catalase gene mutations which could be 
responsible for the highly (less than half of normal) decreased blood 
catalase activity was performed in 380 diabetics (type 1: 115, type 2: 
205, gestational: 60). Highly decreased blood catalase activity was 
detected in 23 patients (6.0 %). These patients had type 1 (6), type 
2 (14), gestational (3) diabetes. Their blood catalase activities were 
less than 52 MU/L which means the 50% of mean (52 MU/L) of the 
controls (104±15 MU/L, n: 295).
The mutational screening of their exons yielded four acatalasemia 
mutations (for type 1: 0, type 2: 3, gestational: 1). These acatalasemia 
mutations were marked as the Hungarian subtypes: H1(c.379CT) 
for the gestational patients, and H2(c.390TC), H3(c.434AT), 
G1(c.106.107insC) for type 2 diabetics. For the controls no one 
yielded either blood catalase activity bellow 52 MU/L (50%), or 
acatalasemia mutation.
From these results in may be concluded that an association 
may exist between the acatalasemia mutations and type 2 diabetes 
(OR: 144.8, 0.95CI: 21.5-974.1), and gestational diabetes (OR:144,8, 
0.95CI: 10.2-2059.6). 
Furthermore, these acatalasemia mutations could explain only 
the decreased (50%) blood catalase activities in 21.4 % (3/14) of type 
2 diabetics, and 33.3% (1/3) of gestational diabetics.
Inherited catalase deficiency (acatalasemia) and 
diabetes mellitus
Acatalasemia refers to inherited deficiency of the catalase 
enzyme. It was one of the first inherited enzyme deficiencies. It was 
detected in Japan by Takahara S. in 1946 and he reported on its nine 
cases in 1952 [23]. To date for acatalasemia there are reports on 118 
homozygotes and 364 heterozygotes in 12 countries. The frequency 
of acatalasemia is 0.08/1000 in Japan, 0.04/1000 in Switzerland, and 
0.05/1000 in Hungary. The 15 genetic mutations of acatalasemia is 
known for 17 homozygous state and for 65 heterozygous state. Of 15 
acatalasemia mutations 12 was detected in Hungarian patients [2,21]. 
Oral gangrene (Takahara disease) was detected in about half of the 
early cases of acatalasemia in the late 1940s and early 1950s when oral 
hygiene was poor in Japan. Due to it, the hydrogen peroxide generated 
by phagocytic cells and oral bacteria could damage the soft tissue in 
the mouth. Later, when oral hygiene improved the prevalence of 
Takahara disease decreased and it ceased [24]. Acatalasemia was 
thought at first to be an asymptotic disorder but recent findings 
suggest that it may be a risk factor in various age related diseases [2].
The first paper on association of acatalasemia and diabetes 
mellitus appeared in 2000 [25].
In 57 Hungarian patients with known acatalasemia mutations 17 
(23.8%) had diabetes mellitus (type 1: 1, type 2:16). These patients 
were from 13 families with 66 non diabetic, normocatalasemic family 
members. It means a significantly higher frequency of diabetes 
(P0.001) in inherited catalase deficiency than its estimated frequency 
(6,5%) in Hungary. 
Table 1 shows that eleven of twelve Hungarian acatalasemia 
mutations that were found in patients with diabetes mellitus. In 
inherited catalase deficiency the type 2 (n:16) is more frequent 
(P0.001) than type 1(n:1) of diabetes mellitus. Among the diabetics 
there are more females (n: 13, 76.4%) than males (n: 4, 23.6%) and 
this is significantly higher (P: 0.0040, Odds ratio: 5.44, 0.95CI: 1.71-
17.26, Risk ratio: 6.80, 0.95CI: 2.01-23.01) when compared to that of 
normocatalasemic family members (female: 80, male: 134) [22]. 
The onset of diabetes for catalase deficient patients (43.1±10.9 
years) appeared more than 10 years earlier (P0.001) than for the 
normocatalasemic subjects (56.3±11.2 years) [26].
Table 1: Hungarian subtypes of acatalasemia mutations in diabetes mellitus.
Type n Homozygote
Hetero
zygote Male Female Catalase % Exon Intron Mutation Protein
 A 2 2 2 4, 6  2 c.138_139insGA p.Val134X
 A*
 B
 C
 D
 F1
 F2
 G1
 H1**
 H2
 H3
4
3
1
1
1
1
1
1
1
2
 4
 3
 1
 1
 1
 1
 1
 1
 1
 2
 2 2 22,46,54,54 2 c.138_139insGA p.Val134X
 3 67,51,54 2 c.79_80insC p.Thr71X
 1 58 7 IVS7+5C˃T
 1 45 9 c.1060G˃A p.Arg354His
 1 53 2 c.161T˃A p.Asp54Glu
 1 52 2 c.201G˃C p.Glu68Asp
 1 44 2 c.106_107insC p.Glu71X
 1 50 4 c.379C˃T p.Arg127Tyr
 1 43 4 c.390T˃C p.Arg130Leu
 1 1 48,43 4 c.431A˃T p.Asp143Val
All 17  2  15  4 14 4-6, 22-67 2,4,9 7
Abbreviations: A* Type 1 n:1, Type 2 n:3, H1** gestational diabetes.
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Furthermore, examination of 36 non diabetic subjects, 
including 18 normocatalasemic subjects and their age-matched 
hypocatalasemic relatives, yielded increased (P0.001) hemoglobin 
A1c (5.49±0.53%) and glucose (5.42±0.80 mmol/l) for catalase 
deficient patients when compared to those of their normocatalasemic 
relatives (hemoglobinA1c:4.88±0.45%, glucose: 4.83±0.46 mmol/L). 
The higher (5.42±0.80 mmol/L) average glucose concentration of 
hypocatalasemic patients may indicate that they have a higher (3.05X) 
risk of type 2 diabetes than their normocatalasemic relatives (glucose: 
4,83±0.46 mmol/L, risk:1.81X) [26,27].
These data suggest, that inherited catalase deficiency may 
contribute to the manifestation of type 2 diabetes mellitus.
Place your text here]
Conclusion
From these results, the following conclusions may be drown. 
 1. Blood catalase activity in diabetes mellitus.
Blood catalase activities were significantly decreased in type 2 
and gestational diabetes without change in type 1 diabetes 
mellitus. 
2. The genetic analyses for explanation of decreased blood catalase 
activity yielded the following results.
It seems that rs769217 (C111T in exon 9, +22348C→T, 
Asp389Asp) a silent mutation and rs1001179 (-262C→T) in the 5’ 
region of catalase gene have no effect on blood catalase activity. 
The significantly higher frequency of diabetes (23.8 %, P0.001, 
compared to the 6.5 % of Hungarians) was found in inherited catalase 
deficiency. It may mean that the increased hydrogen peroxide 
concentration due to the low catalase activity may contribute 
to the damage of the oxidation sensitive pancreatic beta--cells. 
Furthermore, not the type of mutation but the oxidative damage due 
to their lowering effect on blood catalase may play a role in diabetes 
mellitus as 11 of 12 Hungarian acatalasemic mutations were found 
in diabetics.
These data may suggest that the lifelong effect of oxidative damage 
on the oxidant sensitive, insulin producing pancreatic beta-cells 
could contribute to the manifestation of diabetes mellitus especially 
to type 2 form [2,23,25,26,28,29]. These suggestions are in agreement 
with those found in animal experiments. Their authors reported that 
the acatalasemic mice were found susceptible for diabetes hich was 
caused by the oxidative stress of alloxan [30,31]. 
3. For 23 diabetics with decreased (50%) blood catalase activities 
only four (17.4%) acatalasemia mutations could explain the 
reason for the catalase decrease while for the other (82.6 %) 
cases it remains unsolved.
On the basis of these results it may be thought that the decreased 
blood catalase activity in type 2 and gestational diabetes rather due to 
regulatory mechanisms than to the catalase gene mutations. 
Recent findings have revealed such mechanisms. Glorieux C. et 
al., in their review reported that the core promoter of the catalase gene 
has binding sites for transcription factors like NF-Y, Sp1, FoxO3a, 
and PPARγ, Oct-1. These factors may play an essential role in the 
regulation of catalase expression [11]. Dawson NJ, and Storey KB. 
Found that wood frog catalase could be activated by phosphorylation 
of serine and thyrosine of the catalase protein. They are suggesting 
that researchers should explore the activation of catalase enzyme 
by phosphorylation in other catalases especially in human catalase 
enzyme [12]. Veal E et al., reported on the hydrogen peroxide 
signaling which could be enhanced in catalase deficiency [1].
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